South Dakota Investment Council’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

South Dakota Investment Council’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,562	Closed	-$782K	–	643
2023 Q1	$782K	Buy	27,562 +887	+3%	+$26.3K	0.02%	499
2022 Q4	$780K	Buy	26,675 +5,200	+24%	+$165K	0.02%	489
2022 Q3	$567K	Hold	21,475	–	–	0.01%	511
2022 Q2	$954K	Sell	21,475 -70,059	-77%	-$3.22M	0.02%	449
2022 Q1	$4.53M	Sell	91,534 -21,000	-19%	-$1.01M	0.09%	200
2021 Q4	$5.73M	Buy	112,534 +2,930	+3%	+$152K	0.1%	191
2021 Q3	$6.11M	Buy	109,604 +54,010	+97%	+$2.66M	0.11%	179
2021 Q2	$2.38M	Buy	+55,594	New	+$2.29M	0.04%	312

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

South Dakota Investment Council's EGRX Position: Q2 2023 in Review

South Dakota Investment Council sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 27,562 shares — an estimated $782K sold.

South Dakota Investment Council first reported a position in EGRX in Q2 2021 and held it in 8 quarters. The position peaked at $6.11M in Q3 2021. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

South Dakota Investment Council reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
South Dakota Investment Council sold 27,562 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $782K.
South Dakota Investment Council first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2021 and held it in 8 quarters.
South Dakota Investment Council's Eagle Pharmaceuticals, Inc. position peaked at $6.11M in Q3 2021.
126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on South Dakota Investment Council's 13F filing for Q2 2023, filed 10 Aug 2023.